#EPICOVIDEHA has become #EPICOVIDEHA_EPIFLUEHA, expanding its focus to gather viral infection cases in #hematological patients since 2023 #Influenza #Parainfluenza #RSV #SARS_CoV_2 and others!!! More info: journals.lww.com/hemasphere/…

🍄 Abierto el plazo para inscribirse al curso anual Micosis Invasoras Hospitalaras. Formato presencial. 📆27 y 28 de octubre 2026. 📍Salón de actos del Hospital Materno Infantil del Hospital General Universitario Gregorio Marañón. ✍🏼Inscripciones: forms.cloud.microsoft/pages/…

Off to #TheHague for the @EHA_Hematology Education Committee meeting. Always a pleasure, even with the early bird flights! ✈️☕️

🦠 Fungal diseases can have a significant impact on health, yet they can often be overlooked or difficult to diagnose. Fungal Disease Awareness Week takes place 14–18 September, highlighting key issues from diagnosis and antifungal resistance to travel-associated and skin infections. Throughout the week, we’ll be exploring the challenges in recognising and managing fungal diseases. 🔗 Explore our fungal infections resources: touchinfectiousdiseases.com/… @CDCgov #FungalDiseaseAwarenessWeek #ThinkFungus26 #FungalInfections #InfectiousDiseases

13 year old boy presents his research in ISHAM Asia 2026

🔬🇫🇷 How prepared is France for fungal infections? 📊 Survey of 50 centres: 🧪 98% access to susceptibility testing 🔍 98% MALDI-TOF for identification 💊 100% access to major antifungals 🚀 Strong national capacity sciencedirect.com/science/ar…

Awareness of fungal disease is no longer the bottleneck. Action is. Major challenges remain in surveillance, diagnostics, clinical trials and specialist expertise... sciencedirect.com/science/ar…

🦠 Managing viral infections in immunocompromised patients: Key updates from ESCMID 2026 At ESCMID 2026, Dr Jon Salmanton-Garcia (University of Cologne) highlighted how rapidly evolving immunosuppressive therapies are reshaping the landscape of viral infections in vulnerable patients. In this interview, Dr Salmanton-Garcia discusses key advances in diagnostics, including next-generation sequencing and biomarker-driven approaches, alongside rapid progress in vaccine platforms and expanding antiviral options. He also highlights the growing attention on previously under-recognised respiratory viruses and the importance of continued collaboration. Read more: touchinfectiousdiseases.com/… #ESCMID2026 #InfectiousDiseases #Virology #Vaccines #Antivirals

**SAVE THE DATE** The 13th Trends in Medical Mycology will take place in Antwerp, Belgium next year! A Room with a view (conference location) near the Iconic ZOO Antwerpen is the place to be on September 10 till September 13, 2027 for all medical Mycology information. #TIMM13

🌍 17 webinars. 4,631 registrations. Participants from 128 countries. Our 2025 @efisg_escmid series shows the power of digital education to expand global access to expertise in medical mycology. 🍄📚 sciencedirect.com/science/ar…

Fungal Infections collection in @BioMedCentral #Immunology acceps submissions until 25.09.26; reviews welcome! Working on #antifungal_resistance, #novel_therapies, #dermatophytes, #nanotechnology, #host–pathogen_interactions, or related topics? 👉 link.springer.com/collection…

Fungal diseases are often missed in #Africa, affecting diagnosis, treatment and AMR surveillance. Better fungal diagnostics and surveillance must be part of the AMR response. @TheLancet thelancet.com/journals/lanaf…

7 years later, this represents a broader effort across Latin America to understand the current state of diagnostic capabilities for invasive fungal diseases. It is disheartening to see that the most robust diagnostic tools remain microscopy and culture nature.com/articles/s41467-0… 1/3

🦠 Managing viral infections in immunocompromised patients: Key updates from ESCMID 2026 At ESCMID 2026, Dr Jon Salmanton-Garcia (University of Cologne) highlighted how rapidly evolving immunosuppressive therapies are reshaping the landscape of viral infections in vulnerable patients. In this interview, Dr Salmanton-Garcia discusses key advances in diagnostics, including next-generation sequencing and biomarker-driven approaches, alongside rapid progress in vaccine platforms and expanding antiviral options. He also highlights the growing attention on previously under-recognised respiratory viruses and the importance of continued collaboration. Read more: touchinfectiousdiseases.com/… #ESCMID2026 #InfectiousDiseases #Virology #Vaccines #Antivirals

Less can be more 📊 The multicentre E-PEC trial shows a clear shift in #endometrial #cancer #surgery, with increasing use of sentinel lymph node procedures and fewer systematic lymphadenectomies, reflecting a move toward less invasive staging link.springer.com/article/10…

🤓👇🏻

Timely diagnosis of invasive mycoses saves lives 🦠 @efisg_escmid study reveals disparities in access to diagnostics and therapies across #LATAM #Caribbean, highlighting urgent need to strengthen laboratory capacity and improve access to essential drugs nature.com/articles/s41467-0…

📢 We are delighted to announce Dr Franziska Auer as a touchHEMATOLOGY Future Leader 2026! Dr Auer's research focuses on the genetic basis of childhood leukemia, with a particular interest in inherited predisposition to B-cell acute lymphoblastic leukemia and translating genetic discoveries into improved patient care. In this interview, she discusses what inspired her career in pediatric hematology research, the importance of mentorship and collaboration, and her mission to improve outcomes for children with inherited cancer risk. Read more 👉 touchhaematology.com/insight… #FutureLeaders2026 #Hematology #HealthcareLeadership #MedicalEducation #MedicalResearch #ClinicalResearch #HCP #PhysicianLeadership #EmergingLeaders #InnovationInHealthcare #PatientCare #MedEd #MedicalCommunity

The wait is over. Today, we're proud to launch touchHEMATOLOGY Future Leaders 2026, created to recognise, support and celebrate the next generation of leaders shaping the future of hematology. The future of hematology depends on those who are driving innovation, advancing research, collaborating across disciplines and improving outcomes for patients worldwide. touchHEMATOLOGY Future Leaders recognises: 🩸 Excellence in innovation 🩸 Commitment to education and mentorship 🩸 Leadership through collaboration 🩸 Dedication to improving patient outcomes Meet the touchHEMATOLOGY Future Leaders 2026: touchhaematology.com/insight… #FutureLeaders2026 #Hematology #HealthcareLeadership #MedicalEducation #MedicalResearch #ClinicalResearch #HCP #PhysicianLeadership #EmergingLeaders #InnovationInHealthcare #PatientCare #MedEd #MedicalCommunity